Monness Crespi & Hardt Upgrades Monsanto to Neutral (MON)
Other equities research analysts have also recently issued reports about the stock. Analysts at Monness, Crespi, Hardt upgraded shares of Monsanto to a “neutral” rating in a research note to investors on Tuesday. Separately, analysts at Goldman Sachs (NYSE: GS) downgraded shares of Monsanto to a “buy” rating in a research note to investors on Monday, April 9th. They now have a $90.00 price target on the stock. Finally, analysts at Zacks downgraded shares of Monsanto from an “outperform” rating to a “neutral” rating in a research note to investors on Thursday, April 5th. They now have a $85.00 price target on the stock.
Monsanto traded up 0.26% on Tuesday, hitting $72.27. Monsanto has a 1-year low of $58.89 and a 1-year high of $83.95. The company has a market cap of $38.551 billion and a price-to-earnings ratio of 20.37.
Monsanto last released its earnings data on Wednesday, April 4th. The company reported $2.28 EPS for the quarter, beating the Thomson Reuters consensus estimate of $2.11 by $0.17. The company’s quarterly revenue was up 14.9% on a year-over-year basis. Analysts expect that Monsanto will post $-0.23 EPS next quarter.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers.